Top 50 Health Care VC Funds & Investors in Australia (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Uniseed
VC Fund
|
22 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $404k–$22M |
|
Brandon Capital
VC Fund
|
21 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$120M |
|
Artesian VC
VC Fund
|
17 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
16 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.3M–$16M |
|
Uniseed Ventures
VC Fund
|
15 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
Sydney Angels
VC Fund
|
14 | Australia, United States | Seed, Angel, Series A | Software, SaaS, Health Care | $120k–$4.8M |
|
Giant Leap Fund
VC Fund
|
13 | Australia, United States, United Kingdom | Seed, Series A | Health Care, Information Technology, Software | $875k–$23M |
|
Antler
VC Fund
|
13 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Blackbird Ventures
VC Fund
|
11 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $34k–$35M |
|
Breakthrough Victoria
VC Fund
|
11 | Australia, United States, Philippines | Seed, Series A | Health Care, Manufacturing, Biotechnology | $708k–$36M |
|
OneVentures
VC Fund
|
10 | Australia, United States, Israel | Series A, Debt Financing | Software, Health Care, Biotechnology | $1M–$20M |
|
Archangel Ventures
VC Fund
|
10 | Australia, United States, Philippines | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $100k–$22M |
|
Flying Fox Ventures
VC Fund
|
8 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $120k–$5.7M |
|
Stoic VC
VC Fund
|
8 | Australia, United States, United Kingdom | Seed, Series A | Biotechnology, Medical, Health Care | $600k–$16M |
|
OIF Ventures
VC Fund
|
7 | Australia, United States, New Zealand | Seed, Series A | Software, SaaS, FinTech | $1.5M–$23M |
|
Main Sequence Ventures
VC Fund
|
7 | Australia, United States, Philippines | Seed, Series A, Series B | Software, Artificial Intelligence, Manufacturing | $1M–$73M |
|
Airtree Ventures
VC Fund
|
7 | Australia, United States, Singapore | Seed, Series A, Series B | Software, SaaS, Information Technology | $750k–$48M |
|
EVP
VC Fund
|
6 | Australia, New Zealand, United States | Series A, Seed | Software, SaaS, Information Technology | $942k–$5.4M |
|
AfterWork Ventures
VC Fund
|
6 | Australia, United States, New Zealand | Seed, Pre-Seed, Series A | Software, SaaS, FinTech | $367k–$21M |
|
Regal Funds Management
VC Fund
|
6 | Australia, United States, United Kingdom | Convertible Note, Series B | Software, Financial Services, FinTech | $1.7M–$26M |
|
Carthona Capital
VC Fund
|
6 | Australia, United States, United Kingdom | Seed, Series A, Series B | Software, Financial Services, FinTech | $404k–$50M |
|
Brisbane Angels
VC Fund
|
6 | Australia, United States, New Zealand | Seed, Angel, Pre-Seed | Software, Biotechnology, Machine Learning | $120k–$1.3M |
|
Melbourne Angels
VC Fund
|
5 | Australia, United States, New Zealand | Angel, Seed | Biotechnology, Information Technology, Internet | $34k–$1.3M |
|
Australian Medical Angels
VC Fund
|
5 | Australia, Hong Kong | Seed, Pre-Seed, Series A | Health Care, Machine Learning, Sports | |
|
Significant Ventures
VC Fund
|
5 | Australia | Seed, Series A | Manufacturing, Software, Health Care | $67k–$8.2M |
|
Clinton Capital Partners
VC Fund
|
5 | Australia, United States | Seed, Series A | Software, E-Commerce, Health Care | $337k–$5M |
|
Skalata
VC Fund
|
5 | Australia, United States, United Kingdom | Pre-Seed, Seed | Software, Information Technology, Apps | $135k–$2.3M |
|
Black Nova Venture Capital
VC Fund
|
4 | Australia, United States, New Zealand | Seed, Pre-Seed | Software, SaaS, Information Technology | $330k–$3M |
|
Skip Capital
VC Fund
|
4 | Australia, United States, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1.3M–$100M |
|
Investible
VC Fund
|
4 | Australia, United States, Singapore | Seed, Series A, Pre-Seed | Software, Information Technology, FinTech | $221k–$20M |
|
Fund WA
VC Fund
|
4 | Australia | Seed, Series A | Medical, Health Care, Manufacturing | |
|
Tidal Ventures
VC Fund
|
4 | Australia, United States, New Zealand | Seed, Series A, Pre-Seed | Software, SaaS, Information Technology | $508k–$13M |
|
Starfish Ventures
VC Fund
|
4 | United States, Australia, Philippines | Series A, Series B | Software, Enterprise Software, Internet | $2M–$18M |
|
Scalare Partners
VC Fund
|
4 | Australia, Singapore, United States | Seed, Pre-Seed | Software, FinTech, Information Technology | $242k–$5.4M |
|
Transition Level Investments
VC Fund
|
4 | Australia, United States | Seed, Pre-Seed, Series A | SaaS, Software, Health Care | $60k–$2.4M |
|
Antler Australia
VC Fund
|
4 | Australia, Sweden, Philippines | Pre-Seed, Seed, Series A | Software, Financial Services, Information Technology | $128k–$2.7M |
|
QIC BioVentures
VC Fund
|
3 | Australia | Series A | Medical, Health Care, Biotechnology | |
|
Greycroft
VC Fund
|
3 | United States, United Kingdom, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, E-Commerce | $1.5M–$75M |
|
Possible Ventures
VC Fund
|
3 | Germany, Australia, United States | Seed, Pre-Seed, Series A | Software, Biotechnology, Information Technology | $549k–$44M |
|
Folklore Ventures
VC Fund
|
3 | Australia, United States, New Zealand | Seed, Series A | Software, Information Technology, Apps | $500k–$21M |
|
HESTA
VC Fund
|
3 | Australia, United States, Germany | Series B, Private Equity, Series A | Solar, Software, E-Learning | $6.7M–$1.5B |
|
M8 Ventures
VC Fund
|
3 | Australia | Seed, Pre-Seed, Series A | Health Care, SaaS, Medical | $681k–$8M |
|
Right Click Capital
VC Fund
|
3 | Australia, Singapore, United States | Seed, Series A | Software, SaaS, Information Technology | $200k–$16M |
|
TEN13
VC Fund
|
3 | Australia, United States, Kenya | Seed, Series A, Pre-Seed | Software, SaaS, Financial Services | $634k–$46M |
|
Horizons Ventures
VC Fund
|
3 | United States, United Kingdom, Canada | Series A, Series B, Seed | Biotechnology, Software, Artificial Intelligence | $1M–$110M |
|
Purpose Ventures
VC Fund
|
3 | Australia | Seed | EdTech, Medical, Education | $3M–$4M |
|
The George Institute for Global Health
VC Fund
|
3 | Australia | Seed | Biometrics, Health Care, Biotechnology | |
|
BridgeLane Capital
VC Fund
|
3 | Australia, Germany, United States | Seed, Series A | Software, Real Estate, Financial Services | $673k–$6M |
|
Everywhere Ventures
VC Fund
|
3 | United States, Australia, India | Pre-Seed, Seed, Series A | Software, Health Care, FinTech | $550k–$105M |
|
Bailador Technology Investments
VC Fund
|
3 | Australia, United States, New Zealand | Series A, Series B | Software, Health Care, Internet | $1.2M–$16M |
| Access all 346 VC funds in Australia Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 80
- Round size: Seed $600k–$4.2M; Series A $1.6M–$16M; Series B $404k–$22M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap —
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 49
- Round size: Seed $673k–$6.7M; Series A $4.9M–$81M; Series B $5M–$120M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 223
- Round size: Seed $120k–$4M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
- Living Models — Living Models is concentrating on this field by employing AI methods on biological data, especially in plant science, where enhancing crop yield and resilience is becoming crucial as global agriculture is impacted by climatic challenges.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 25
- Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Angel, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 93
- Round size: Seed $120k–$1.3M; Angel $130k–$890k; Series A $250k–$4.8M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Okkular — Okkular is an AI based fashion tech startup.
- iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more...Investment focus
- Industry: Health Care, Information Technology, Software
- Stage:Seed, Series A
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 44
- Round size: Seed $875k–$4.2M; Series A $2.8M–$23M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $9.7M in 2018
Portfolio highlights
- Indi — indi is an assistant for your child's care journey; supporting advocacy, mental health & uniting the village of care.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
- Clean Slate Clinic — Clean Slate Clinic is a telehealth company that provides alcohol detox program who are struggling with alcohol.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 935
- Round size: Seed $362k–$5.8M; Pre-Seed $100k–$1.3M; Series A $4.6M–$29M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $72M in 2024
Portfolio highlights
- Gyodi —
- Pathzero — Pathzero's carbon management platform enables any business to start disclosing corporate carbon emissions and the actions being taken to address them.
- Unseen — Unseen is a market intelligence platform for commercial real estate.
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 306
- Round size: Seed $34k–$7M; Pre-Seed $50k–$3M; Series A $3.3M–$35M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Sumday — Non - financial accounting software. Start carbon accounting, properly, with the support of your existing advisors
- Polymath — Personalised learning and fun means you can be confident that your child is getting the learning experience they want and deserve.
- Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 45
- Round size: Seed $708k–$7.1M; Series A $1.8M–$36M
- Lead/follow: 62% lead, 38% follow
Portfolio highlights
- DeepDerm — DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies.
- InnovaIVF — InnovaIVF transforms the reproductive technology landscape with innovative solutions.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Debt Financing
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 71
- Round size: Series A $1.5M–$20M; Debt Financing $1M–$6.7M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $145M in 2022
Portfolio highlights
- Hometime — At Hometime, we provide Airbnb property management solutions for homeowners and rental management business owners that help them scale and earn more.
- MyPass Global — MyPass Global is award-winning workforce management software. Join 100's of organisations to reduce costs & simplify compliance, resourcing & recruitment.
- AMP — We make life simpler for merchants navigating the exponential growth of eCommerce with our suite of powerful software, global community, and educational resources.
Archangel is an early stage venture capital fund based in Australia. We work with great founders and investors to build game changing companies together.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 55
- Round size: Seed $750k–$4.3M; Pre-Seed $100k–$1.2M; Series A $3.3M–$22M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
- Flowing Bee — Revolutionise your customer interactions using AI, customer and behavioural insights. We create powerful marketing communications that drive behaviour change.
- Fluency — Experience real-time visibility into how work happens. Measure ROI on GenAI initiatives, tie execution directly to KPIs, and automatically discover and optimize workflows. All without heavy integrations.
Flying Fox Ventures is an early stage investment firm that invests across industry and across the micro-stages of pre-seed and seed.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 102
- Round size: Seed $661k–$3.2M; Pre-Seed $120k–$3M; Series A $649k–$5.7M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Predelo — Streamline workflows and optimize operations with Predelo's AI-driven automation. Discover the benefits of our solutions and stay ahead!
- Mayday — Streamline your finance team's multi-entity accounting adjustments with Mayday
- Mass Dynamics — Mass Dynamics exists to enable more life scientists to accelerate their studies using Mass Spectrometry (MS). It's our contribution towards enriching lives and freeing humanity and society from the burden of disease. Mass Dynamics includes Enrichment Analysis based on GSEA algorithms and utilises Gene Ontology (GO) and Reactome knowledge bases.
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $600k–$4.2M; Series A $7.6M–$16M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
- Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
OIF is a venture capital firm focusing on partnering with entrepreneurs building businesses.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 61
- Round size: Seed $1.5M–$5M; Series A $2.7M–$23M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $65M in 2020
Portfolio highlights
- Zitcha — Zitcha builds own-branded, high-performance, Retail Media Businesses by connecting Retailers and Brands to all marketing channels in one omnichannel platform, onsite, offsite and in-store.
- Appetise — MenuAid is a cheaper, flexible and more sustainable alternative to meal-kit delivery providers. We provide Kiwis with a weekly meal plan, complete with recipes and a list of ingredients that can either be self-shopped or collected/delivered from your favourite supermarkets.
- Payble — Payble offers insight led flexible payment options and customer engagement tools for a proactive approach to rates collections. Get more control and never miss a bill again!
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Manufacturing
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 121
- Round size: Seed $1M–$7.1M; Series A $4.5M–$29M; Series B $13M–$73M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $303M in 2023
Portfolio highlights
- Xefco — Xefco is a company that develops novel textile and coating technologies. It uses a global network of research partners to develop advanced manufacturing solutions and apply cutting-edge materials science, with an emphasis on functional enhancements, sustainable manufacturing, and decreased resource consumption.
- ElectraLith — The cleanest, most versatile and most cost-efficient method of extracting and refining lithium, the primary element of a sustainable future.
- Quantum Brilliance — Quantum Brilliance builds diamond-based quantum chips and products that operate at room temperature, enabling mass-deployable quantum technology from data centers to the field.
AirTree is a venture capital firm investing in Australian and New Zealand technology founders from seed stage or earlier.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Singapore
Investor stats
- Total investments: 181
- Round size: Seed $750k–$11M; Series A $2.8M–$35M; Series B $4M–$48M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $288M in 2022
Portfolio highlights
- Sauce — AI customer insights for product teams
- SafetyCulture — Digitize & improve elements of your operations. Give your teams the knowledge, tools & confidence to work safely & meet higher standards.
- Pocket Universe — Pocket Universe is a browser extension that keeps your assets safe when you sign web3 transactions
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Seed
- Geography: Australia, New Zealand, United States
Investor stats
- Total investments: 102
- Round size: Seed $942k–$2.5M; Series A $1.2M–$5.4M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- Veridooh — Use Veridooh to increase the effectiveness of your out-of-home advertising with automation, independent verification, and actionable intelligence - all in one easy-to-use, collaborative platform.
- InvestorHub — We provide comprehensive access to listed capital raises for institutional, family office and high net worth investors.
- Deckard Technologies — Deckard Technologies provides city and county governments the analytics and insights they need to ensure tax fairness and equity in their jurisdictions by recovering mandated property and transient occupancy taxes. Using AI and a massive data collection, the Deckard platform performs analysis of hundreds-of-millions of images and data points,giving local governments greater visibility into the commercialization of residential neighborhoods and property upgrades, through two products: Rentalscape and Propertyscape. Deckard’s partnership with local communities saves them time and money, increases productivity, and enables them to make informed policy decisions while determining their own thresholds for the sharing economy. The recovered taxes support the common good of the local communities, including essential services like schools, infrastructure, fire departments, and safety.
We are a community-powered VC fund making pre-seed / seed stage investments in Australian and New Zealand startups. Our community is rallied around a shared goal: to invest in the next generation of Australia and New Zealand startups at the very earliest stage, and then support them on their long a
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 81
- Round size: Seed $367k–$2.5M; Pre-Seed $410k–$2.2M; Series A $4.2M–$21M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
- PropHero — Invest wisely in real estate There is an easier way to invest in real estate. Whether you are just getting started or already on your investment journey, at Pro
- Samphire Neuroscience — Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Convertible Note, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Series B $7M–$26M; Convertible Note $1.7M–$17M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- Carma — Want to sell or trade in your old car? Good news: Carma takes care of both! Get a valuation online, with easy drop-off and seamless transition between cars.
- Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
- Amaero International — Amaero International is a manufacturer of high-temperature powder metals and specialty powders. The company produces refractory, titanium, and specialty alloyed powders using gas atomization and hot isostatic pressing (HIP) technologies. Amaero International serves sectors including defense, aerospace, energy, and medical.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 111
- Round size: Seed $404k–$4.2M; Series A $3.3M–$17M; Series B $9.8M–$50M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Pathzero — Pathzero's carbon management platform enables any business to start disclosing corporate carbon emissions and the actions being taken to address them.
- CoverRight — Use CoverRight's tools to find a personalized Medicare plan and get the best coverage for your situation! Compare and enroll in Medicare Advantage, Medigap, and Prescription Drug Plans, all in one place.
- Lounge — Use Lounge to organise events and groups in seconds, without a newsfeed. Stop scrolling, start living.
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 45
- Round size: Seed $120k–$1.3M; Angel $337k–$629k; Pre-Seed $200k–$1.3M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Tendl — Write tenders faster with Tendl's AI tool. Keep your data private and secure. Easy installation, no sharing. Boost productivity and streamline your contract opportunities.
- Shopfront — Automate multi-channel selling across eBay, Depop, Grailed & Shopify. AI-powered listings, bulk uploads, inventory sync.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Internet
- Stage:Angel, Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 40
- Round size: Seed $34k–$1.3M; Angel $219k–$918k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Insite AI — The chosen partner by executives in RGM, insights, and I.T. to grow revenue and market share. Learn how CPGs win in pricing, assortment, trade and more.
- Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more...Investment focus
- Industry: Health Care, Machine Learning, Sports
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, Hong Kong
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
- Clean Slate Clinic — Clean Slate Clinic is a telehealth company that provides alcohol detox program who are struggling with alcohol.
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 25
- Round size: Seed $67k–$5M; Series A $4.5M–$8.2M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Wavewise Analytics — Cyban is a medical equipment manufacturing company that manufactures brain oxygen monitors.
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Visionary Machines — Superior perception for next-generation autonomy
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 65
- Round size: Seed $337k–$2.4M; Series A $740k–$5M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
- PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
- FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
Giving Australian founders access to the education, capital and networks needed to build significant, sustainable, global businesses of the future.
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Pre-Seed, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 78
- Round size: Seed $135k–$2.3M; Pre-Seed $135k–$500k
- Lead/follow: 86% lead, 14% follow
- Last fund: Likely still investing — raised $18M in 2021
Portfolio highlights
- TALY — TALY is a platform that is designed to find, manage and retain employees from both perfromance and personality for business development.
- Viewa — Viewa is an augmented reality(AR) content publishing platform that brings print media such as magazines to life in 3D.
- Termina — Termina operates as an energy tech startup.
Championing the next generation of B2B technology startups.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 41
- Round size: Seed $457k–$3M; Pre-Seed $330k–$2.7M
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- 8seats — 8seats offers a secure, effortless messaging app for teams! Boost productivity with real-time chat, team collaboration for businesses of any size. Get started for free!
- Nullify — Nullify performs product security tasks alongside your developers.
- SPEC Toolbox — CLT Toolbox offers sustainable design of structural materials, using software to clear through the clutter and make design simple. CLT Toolbox is building structural design software to make mass timber as easy as concrete or steel.
Skip Capital is a private investment fund investing in technology and infrastructure
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Australia, United States, Canada
Investor stats
- Total investments: 78
- Round size: Seed $1.3M–$10M; Series A $4M–$60M; Series B $10M–$100M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Reejig — At Reejig, we believe in zero wasted potential in people and in business – and that starts with harnessing the skills you have within your organisation. Our workforce intelligence platform provides 100% visibility of your people’s skills, potential, passions and experiences, creating a powerful central nervous system for all talent decisions.Powered by the world’s first independently audited Ethical Talent AI engine, Reejig generates the intelligence to instantly fill roles, track retention risks, mobilise talent to opportunities, pivot talent for reskilling and much more. Plus, we give you the power to ‘nudge’ people to new career opportunities, taking your engagement with internal and external talent to the next level. Put simply, we make workforce agility a reality.Reejig is trusted and used by some of the largest and most complex organisations including Woolworths, KPMG, NSW Government, John Holland, MYOB and UTS, and together we are creating a world where everyone can reach their full potential at work. It’s what we call zero-wasted potential in people and in business.
- Brighte — Brighte makes solar, battery and home improvements affordable for Aussies with easy finance and a network of trusted tradies.
- WORK180 — WORK180 is a global jobs network that operates at the forefront of a new workplace revolution. Our function is twofold.As an advocate for working women, we provide job applicants with a transparent directory of endorsed employers who support diversity, inclusion and equality.We share information around pay equity, flexible working, paidparental leave, equal opportunities and a range of other important criteria. Before an employer comes on board, we put them through a pre-screening process and on average, about 80% of companies who apply to work with us, pass our criteria.
Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Singapore
Investor stats
- Total investments: 163
- Round size: Seed $221k–$5.3M; Pre-Seed $404k–$2M; Series A $1.4M–$20M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Stables — Save, spend and earn on the same balance
- Mosaic Solutions — Find the top POS supplier in the Philippines for your business needs. Get reliable, efficient, and affordable point-of-sale solutions today!
- Quantum Brilliance — Quantum Brilliance builds diamond-based quantum chips and products that operate at room temperature, enabling mass-deployable quantum technology from data centers to the field.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 7
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Enzide — Plastic without Pollution: What if there was a way to make plastic harmless and go away when it's no longer needed? With Australia's best scientists we’ve developed super enzyme technology that makes this possible.
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
We are a highly experienced Australian-US venture capital firm ready to back seed phase startups with brilliant ideas & global potential.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 51
- Round size: Seed $1M–$7M; Pre-Seed $508k–$1.3M; Series A $1M–$13M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Operata — Continuously measure performance to deliver the best possible customer experience.
- upflowy — Build and AB test your lead and signup flow faster than ever with our no-code engine.
- Flagship — Flagship provides retailers with a centralized Visual Merchandising platform that enables the creation, execution and review of Visual Merchandising directives.
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Series A, Series B
- Geography: United States, Australia, Philippines
Investor stats
- Total investments: 53
- Round size: Series A $2M–$6.6M; Series B $2.5M–$18M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $134M in 2008
Portfolio highlights
- Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
- DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
- Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Scalare Partners is more than a technology investment fund. We provide critical funding and resourcing
Show more...Investment focus
- Industry: Software, FinTech, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Australia, Singapore, United States
Investor stats
- Total investments: 33
- Round size: Seed $242k–$5.4M; Pre-Seed $472k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Brauz — Brauz connects your customers now with Reserve In Store, Find in Store, Click + Collect, On Demand Delivery, Ship from Store, Appointment Booking, Video Commerce, Clienteling and more.
- Betterx — Betterx is a technology company focused on infrastructure to support Web3.0 and Digital Assets.
- Amelio Health — Amelio Health is a program integrating a set of pathways developing the capabilities of case managers to signpost claimants at risk of developing chronic pain
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia, United States
Investor stats
- Total investments: 19
- Round size: Seed $875k–$2.4M; Pre-Seed $60k–$1.5M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
- Kapiche — Customer intelligence for CX, support and product teams who need to understand their customers accross more than just surveys. Analyze 100% of customer conversations to prevent churn and accelerate growth.
- Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Australia's only truly global early stage VC, we believe in and back the most ambitious founders from the earliest stage.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Australia, Sweden, Philippines
Investor stats
- Total investments: 20
- Round size: Seed $128k–$2.7M; Pre-Seed $128k–$200k
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- upcover — upcover is Australia's award winning Online business insurance provider for All type of business owners, startups, consultants, freelancers and gig economy workers in Australia. Get a quote online today.
- Pathzero — Pathzero's carbon management platform enables any business to start disclosing corporate carbon emissions and the actions being taken to address them.
- ReFresh — ReFresh is the psychosocial operating system that gives safety and people leaders their time back. Risk intelligence, safety orchestration, and governance evidence in one OS.
QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
- Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Venture capital and technology investments
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 693
- Round size: Seed $1.5M–$8.5M; Series A $3.1M–$23M; Series B $6.2M–$75M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $378M in 2023
Portfolio highlights
- Peer AI — The AI platform for life sciences regulatory submissions. Author documents faster, orchestrate programs in real time, and anticipate queries before filing.
- Guidesly — Find the best fishing charters & fishing guides. Search and book from THOUSANDS of top fishing charters across the United States. Explore trips today
- Veritonic — Veritonic is a marketing analytics platform that offers online testing and optimization services for firms in the music industry.Veritonic’s product portfolio consist of testing, analytics, and workflow. Testing assists its users in making data-driven decisions, measuring emotional response, and obtaining qualitative and quantitative responses.Analytics assists its users in benchmarking their brand progress. Workflow enables its users to manage, save, and share tracks with others.Veritonic was founded in 2015 by Andrew Eisner and Scott Simonelli.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Australia, United States
Investor stats
- Total investments: 162
- Round size: Seed $1.6M–$10M; Pre-Seed $549k–$3.8M; Series A $9.5M–$44M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- EntryLevel — Learn in an affordable, peer-driven environment over 6 weeks with mentors from top companies across the world such as Atlassian, Wise and more.
- VSPARTICLE — VSPARTICLE develops nanoparticle generators for various applications such as sensors, batteries, catalysis, solar cells, healthcare, additive manufacturing, nano safety, and more. It also enables research and industry to generate new materials at the push of a button.They specialize in nanoparticle production and integration. The technologyspeeds up the developments of customers by producing the desired nanoparticles on location and integrate them directly in the final product. VSPARTICLE was founded in 2014 and is headquartered in Delft, The Netherlands.
- Auriga Space — Next-generation space launch company providing frequent, sustainable and affordable transport to low Earth orbit
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more...Investment focus
- Industry: Software, Information Technology, Apps
- Stage:Seed, Series A
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 45
- Round size: Seed $725k–$5M; Series A $500k–$21M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Arkeus — Arkeus is a leader in the fusion of optics and autonomy. Our wide area autonomous optical systems are deployed to conduct Search, Intelligence, Surveillance and Reconnaissance in a range of operating environments.
- Sphere — Live courses led by vetted experts for professionals who want to advance their careers
- Visionary Machines — Superior perception for next-generation autonomy
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.
Show more...Investment focus
- Industry: Solar, Software, E-Learning
- Stage:Series B, Private Equity, Series A
- Geography: Australia, United States, Germany
Investor stats
- Total investments: 14
- Round size: Series A $6.7M–$17M; Series B $20M–$27M; Private Equity $81M–$1.5B
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
- SafetyCulture — Digitize & improve elements of your operations. Give your teams the knowledge, tools & confidence to work safely & meet higher standards.
- Pine Gate Renewables — Award-winning national solar energy developer for capital investors, energy buyers, landowners and communities across the United States.
Great tech startup businesses are built by amazing product teams
Show more...Investment focus
- Industry: Health Care, SaaS, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 5
- Round size: Seed $3M–$8M; Pre-Seed $681k–$1M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
- Flowing Bee — Revolutionise your customer interactions using AI, customer and behavioural insights. We create powerful marketing communications that drive behaviour change.
Right Click Capital - Australian Venture Capital Firm
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Australia, Singapore, United States
Investor stats
- Total investments: 61
- Round size: Seed $200k–$3.6M; Series A $3.3M–$16M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- black.ai — Build smarter spaces with Black.ai
- Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
- Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
TEN13 is Australia's leading Venture Capital Syndicate.
Show more...Investment focus
- Industry: Software, SaaS, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Kenya
Investor stats
- Total investments: 78
- Round size: Seed $634k–$8M; Pre-Seed $808k–$2.2M; Series A $3.7M–$46M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Drawboard — Remarkable markup tools for WIndows 10, iOS and your web browser. Download for free today.
- Instant — The world's best-performing online checkout that maximises revenue for your brand!
- Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Biotechnology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 250
- Round size: Seed $1M–$11M; Series A $6.2M–$50M; Series B $8M–$110M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
- Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more...Investment focus
- Industry: EdTech, Medical, Education
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 5
- Round size: Seed $3M–$4M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
- My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
The George Institute is on a mission to improve the health of millions of people worldwide. Join us in our fight for a healthier world.
Show more...Investment focus
- Industry: Biometrics, Health Care, Biotechnology
- Stage:Seed
- Geography: Australia
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellSync — CellSync is a Biotechnology Research firm that is working to make changes in the Future of Cell Engineering.
- Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
- Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme
Show more...Investment focus
- Industry: Software, Real Estate, Financial Services
- Stage:Seed, Series A
- Geography: Australia, Germany, United States
Investor stats
- Total investments: 20
- Round size: Seed $673k–$4.2M; Series A $3M–$6M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- MadeComfy — Award-winning Airbnb management service in Australia and New Zealand. MadeComfy is a selected official partner of Airbnb. Find out how we earn you higher returns with short-term rentals.
- Futurerent — Futurerent is a tool that offers solutions to residential property investors for investment capital and cashflow needs.
- Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, India
Investor stats
- Total investments: 262
- Round size: Seed $1.5M–$7M; Pre-Seed $550k–$2.5M; Series A $7.3M–$105M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- VAMA — VAMA is a one-stop virtual platform that provides easy access to e-pujas, e-darshans, and astrology services, to devotees from across India and the world.
- Presta — Presta provides digital lending infrastructure for the banking industry. The company was founded in 2022 and is headquartered in Cleveland, Ohio.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
Bailador is a growth capital fund that focuses on the IT and media sectors, managed by an experienced team with demonstrated sector expertise. The company supports its portfolio companies in subsequent rounds of funding through their own participation and with introductions to larger international growth expansion funds. It assists in thepreparation and management of fundraising, M&A activity, and pre-IPO processes. The portfolio businesses of the company are DocsCorp, Click Loans Group, Rezdy, Stackla, iPRO Solutions, and SiteMinder.Bailador is an Australia-based company that was founded in 2010 by Paul Wilson and David Kirk.
Show more...Investment focus
- Industry: Software, Health Care, Internet
- Stage:Series A, Series B
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 27
- Round size: Series A $1.2M–$16M; Series B $3.4M–$4.3M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- Rosterfy — Connect to your volunteers with a comprehensive & user-friendly platform where you can recruit, retain, reward and train your volunteers.
- Instaclustr — Instaclustr Managed and supported platform for open source technologies. Apache Cassandra, Apache Kafka, OpenSearch, PostgreSQL and Redis.
- DASH Technology — DASH Technology provides financial services. They provide software, platform, and even wealth management space services. They provide advisers and broader wealth services. They provide inquiries through email, phone calls, and online applications.
Health Care VC funding in Australia at a glance
Stats across 426 deals from 346 investors.
Access all 346 VC funds in Australia Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 346 VC funds investing in Australia Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!